210 related articles for article (PubMed ID: 31821342)
1. Human recombinant erythropoietin improves motor function in rats with spinal cord compression-induced cervical myelopathy.
Tanaka T; Murata H; Miyazaki R; Yoshizumi T; Sato M; Ohtake M; Tateishi K; Kim P; Yamamoto T
PLoS One; 2019; 14(12):e0214351. PubMed ID: 31821342
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin prevents motor neuron apoptosis in a rat model of cervical sub-acute spinal cord compression.
Ning B; Zhang A; Song H; Gong W; Ding Y; Guo S; Zhao Y; Jiang J; Jia T
Neurosci Lett; 2011 Feb; 490(1):57-62. PubMed ID: 21167907
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte Colony-Stimulating Factor Improves Motor Function in Rats Developing Compression Myelopathy.
Yoshizumi T; Murata H; Yamamoto S; Kurokawa R; Kim P; Kawahara N
Spine (Phila Pa 1976); 2016 Dec; 41(23):E1380-E1387. PubMed ID: 27120060
[TBL] [Abstract][Full Text] [Related]
4. Cilostazol, a selective Type III phosphodiesterase inhibitor: prevention of cervical myelopathy in a rat chronic compression model.
Yamamoto S; Kurokawa R; Kim P
J Neurosurg Spine; 2014 Jan; 20(1):93-101. PubMed ID: 24206033
[TBL] [Abstract][Full Text] [Related]
5. The neuroprotective effect of erythropoietin on spinal motor neurons after nerve root avulsion injury in rats.
Noguchi T; Ohta S; Kakinoki R; Ikeguchi R; Kaizawa Y; Oda H; Matsuda S
Restor Neurol Neurosci; 2015; 33(4):461-70. PubMed ID: 26409405
[TBL] [Abstract][Full Text] [Related]
6. The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats.
Cetin A; Nas K; Büyükbayram H; Ceviz A; Olmez G
Eur Spine J; 2006 Oct; 15(10):1539-44. PubMed ID: 16547753
[TBL] [Abstract][Full Text] [Related]
7. Methylprednisolone treatment enhances early recovery following surgical decompression for degenerative cervical myelopathy without compromise to the systemic immune system.
Vidal PM; Ulndreaj A; Badner A; Hong J; Fehlings MG
J Neuroinflammation; 2018 Aug; 15(1):222. PubMed ID: 30081922
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and erythropoietin receptor expression after experimental spinal cord injury encourages therapy by exogenous erythropoietin.
Grasso G; Sfacteria A; Passalacqua M; Morabito A; Buemi M; Macrì B; Brines ML; Tomasello F
Neurosurgery; 2005 Apr; 56(4):821-7; discussion 821-7. PubMed ID: 15792521
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammation and apoptosis after surgery for a rat model of double-level cervical cord compression.
Yao M; Li G; Pu PM; Zhou LY; Li ZY; Liu SF; Sng KS; Zheng Z; Song YJ; Zhu K; Wang YJ; Cui XJ
Neurochem Int; 2022 Jul; 157():105340. PubMed ID: 35398187
[TBL] [Abstract][Full Text] [Related]
10. Postdecompressive spinal cord blood flow increments in a cervical chronic myelopathy model in rats.
Yamamoto S; Kurokawa R; Kim P
J Neurosurg Spine; 2021 Jun; 35(2):202-210. PubMed ID: 34144516
[TBL] [Abstract][Full Text] [Related]
11. Delayed administration of recombinant human erythropoietin reduces apoptosis and inflammation and promotes myelin repair and functional recovery following spinal cord compressive injury in rats.
Yang L; Yan X; Xu Z; Tan W; Chen Z; Wu B
Restor Neurol Neurosci; 2015 Oct; 34(4):647-63. PubMed ID: 26444376
[TBL] [Abstract][Full Text] [Related]
12. Synergetic Induction of NGF With Diazoxide and Erythropoietin Attenuates Spinal Cord Ischemic Injury.
Yamanaka K; Eldeiry M; Aftab M; Ryan TJ; Meng X; Weyant MJ; Fullerton DA; Reece TB
J Surg Res; 2019 Jan; 233():124-131. PubMed ID: 30502238
[TBL] [Abstract][Full Text] [Related]
13. Zonisamide ameliorates progression of cervical spondylotic myelopathy in a rat model.
Kanbara S; Ohkawara B; Nakashima H; Ohta K; Koshimizu H; Inoue T; Tomita H; Ito M; Masuda A; Ishiguro N; Imagama S; Ohno K
Sci Rep; 2020 Aug; 10(1):13138. PubMed ID: 32753675
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury.
Celik M; Gökmen N; Erbayraktar S; Akhisaroglu M; Konakc S; Ulukus C; Genc S; Genc K; Sagiroglu E; Cerami A; Brines M
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2258-63. PubMed ID: 11854521
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.
Yoo JY; Won YJ; Lee JH; Kim JU; Sung IY; Hwang SJ; Kim MJ; Hong HN
J Neurosci Res; 2009 Jan; 87(1):150-63. PubMed ID: 18711747
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats.
Okutan O; Solaroglu I; Beskonakli E; Taskin Y
J Clin Neurosci; 2007 Apr; 14(4):364-8. PubMed ID: 17236773
[TBL] [Abstract][Full Text] [Related]
17. Delayed myelopathy induced by chronic compression in the rat spinal cord.
Kim P; Haisa T; Kawamoto T; Kirino T; Wakai S
Ann Neurol; 2004 Apr; 55(4):503-11. PubMed ID: 15048889
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment with erythropoietin attenuates the neurological injury after spinal cord ischemia.
Hwang J; Huh J; Kim J; Jeon Y; Cho S; Han S
Spinal Cord; 2012 Mar; 50(3):208-12. PubMed ID: 22124347
[TBL] [Abstract][Full Text] [Related]
19. Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative.
Grasso G; Sfacteria A; Erbayraktar S; Passalacqua M; Meli F; Gokmen N; Yilmaz O; La Torre D; Buemi M; Iacopino DG; Coleman T; Cerami A; Brines M; Tomasello F
J Neurosurg Spine; 2006 Apr; 4(4):310-8. PubMed ID: 16619678
[TBL] [Abstract][Full Text] [Related]
20. Limaprost alfadex, a prostaglandin E1 derivative, prevents deterioration of forced exercise capability in rats with chronic compression of the spinal cord.
Kurokawa R; Nagayama E; Murata H; Kim P
Spine (Phila Pa 1976); 2011 May; 36(11):865-9. PubMed ID: 21192291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
